Pfizer’s Trumenba® Approved By European Commission For Meningococcal Group B Disease May 31, 2017 Pfizer Inc. (NYSE:PFE) announced that the European Commission (EC) has approved TRUMENBA® (Meningococcal Group B Vaccine) for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroup B (MenB) in individuals 10 years of age [..]
Moisture-Responsive Breathable Workout Suit: Designed By MIT Scientists A team of MIT researchers has designed a breathable workout suit with ventilating flaps that open and close in response to an athlete’s body heat and sweat. These flaps, which range from thumbnail- to finger-sized, are lined with live microbial [..]
Genentech’s Actemra (Tocilizumab) for Giant Cell Arteritis Is Now Approved by FDA FDA previously granted Priority Review and Breakthrough Therapy Designation for Actemra in GCA Sixth FDA approval for Actemra since its U.S. launch in 2010 Source: Genentech NEWS May 23, 2017 Genentech, a member of the Roche Group (SIX: [..]
FDA Approved KALYDECO® To Treat Additional Mutations of Cystic Fibrosis Source: Vertex Pharmaceuticals Inc. News Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced that the U.S. Food and Drug Administration (FDA) has approved KALYDECO® (ivacaftor) for use in people with cystic fibrosis (CF) ages 2 and older who have one of 23 [..]
C-LEARN: A New Approach To Teach Robots With Robots Source: Adam Conner-Simons | CSAIL MIT May 10, 2017 Most robots are programmed using one of two methods: learning from demonstration, in which they watch a task being done and then replicate it, or via motion-planning techniques such as optimization or sampling, [..]
Noval Way To Clear Pollutants From Water By: David L. Chandler | MIT News Office May 14, 2017 When it comes to removing very dilute concentrations of pollutants from water, existing separation methods tend to be energy- and chemical-intensive. Now, a new method developed at MIT could provide a selective [..]
New Chemical “Dye” To Improve Liver Cancer Imaging By: NUS News 14 May 2017 Scientists from the National University of Singapore (NUS) have developed a novel nanodiamond-based contrast agent – a chemical “dye” used to enhance the visibility of internal body structures in magnetic resonance imaging (MRI) – that improves visualisation of liver [..]
New Technology To Monitor And Maintain The Drug Levels In The Body May 12, 2017 By: Tom Abate | Stanford News As with coffee or alcohol, the way each person processes medication is unique. One person’s perfect dose may be another person’s deadly overdose. With such variability, it can be [..]
A New Leap In Quantum Computing By Stanford Team By: Tom Abate (Stanford News) May 11, 2017 For 60 years computers have become smaller, faster and cheaper. But engineers are approaching the limits of how small they can make silicon transistors and how quickly they can push electricity through devices to [..]
Key Step Identified In Lung Cancer Evolution By MIT Biologist By: Anne Trafton | MIT News Office May 11, 2017 Lung adenocarcinoma, an aggressive form of cancer that accounts for about 40 percent of U.S. lung cancer cases, is believed to arise from benign tumors known as adenomas. MIT biologists [..]
Exotic Electronic States of Graphene Source: Jennifer Chu | MIT News Office May 9, 2017 In normal conductive materials such as silver and copper, electric current flows with varying degrees of resistance, in the form of individual electrons that ping-pong off defects, dissipating energy as they go. Superconductors, by contrast, [..]
FDA Approve RADICAVA™ of MT Pharma America To Treat ALS First FDA-approved ALS treatment option in more than 20 years1 RADICAVA has been demonstrated to slow decline of physical function by 33 percent2 Comprehensive clinical development program in ALS conducted over a 13-year period2 Source: MT America News May 9, [..]
FDA Granted Approval To Novartis Rydapt® For Acute Myeloid Leukemia Approval in newly diagnosed FLT3-mutated AML represents the first new treatment in more than 25 years[1],[2] Rydapt treatment regimen in FLT3-mutated AML demonstrated a significant improvement in overall survival with a 23% reduction in the risk of death[3] Rydapt is [..]
Copyright © 2024 | WordPress Theme by MH Themes